Summary:
The RESET Study is a randomized, double-blind, placebo-controlled, Phase 4 study, that is aiming to enroll approximately 1100 patients with recurrent depression at approximately 60 study centers across the Untied States.
Qualified Participants Must:
• Have current major depressive episode which has lasted 2-18 months
•
Have had at least two previous major depressive episodes
•
Be between 18 and 75 years of age, inclusive
Qualified Participants May Receive:
Study care and exams at no cost and also a stipend of $75 per visit.